Testing if amylin can trigger migraine attacks
Treatments studied
Part of Brain & nervous system, Pain clinical trials.
This study tests whether a natural substance called amylin can trigger a migraine attack in people who get migraine without aura. If you have 1 to 5 migraine days a month and are otherwise healthy, you may be able to help researchers understand what causes migraines.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are between 18 and 65 years old.
- Your weight is between 110 and 220 pounds (50 to 100 kg).
- You have had migraine without aura for at least one year and have 1 to 5 migraine days per month.
- You do not have any other type of headache disorder, heart or lung disease, or a history of head injury.
- You do not take any daily medications (except birth control) and can avoid caffeine, nicotine, and alcohol for 12 hours before the study.
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests if people with long-term headache after a mild head injury are sensitive to a natural substance called amylin. It may help find new ways to treat this type of headache.
This trial tests a substance that activates adrenomedullin receptors, which may be a new way to treat migraines. It may help people who have migraines without aura and aren't on preventive migraine medications.
This study tests new ways to monitor how well preventive migraine treatments are working. It is for people with chronic migraine who may be starting or already using preventive medications.
This trial looks at the chemical changes in the blood of people with migraine. It aims to better understand the disease and may help find new treatments. You may qualify if you have episodic or chronic migraine and have not tried CGRP-targeting drugs.
This study looks for new biological markers in people whose migraines don't respond to standard treatments. It aims to better understand why some migraines are hard to treat and may help guide future therapies.
This study looks at how certain immune cells and inflammatory chemicals relate to migraines. If you have migraines or an autoimmune condition (like lupus, rheumatoid arthritis, or Crohn's disease), you may be able to participate. The goal is to understand what causes migraines.
Hear when a new Headache Disorders, Primary trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.